Iron deficiency alters dopamine uptake and response toL-DOPA injection in Sprague–Dawley rats.

Bianco, Laura E.; Wiesinger, Jason; Earley, Christopher J.; Jones, Byron C.; Beard, John L.

Iron deficiency (ID) disrupts brain dopamine (DA) and norepinephrine (NE) metabolism including functioning of monoamine transporters and receptors. We employed caudate microdialysis and no net flux (NNF) in post-weaning rats to determine if ID decreased the extraction fraction ( Ed). Five micromolar quinpirole, a dopamine D2 receptor agonist, resulted in 80% decrease in extracellular DA and 45% higher Ed in control animals. The D2 agonist had no effect on Ed in ID animals despite a reduction in basal DA. DAT mRNA levels were reduced by 58% with ID, while DAT protein in ventral midbrain and caudate and membrane associated DAT were also reduced by ID. Carbidopa/l-DOPA was administered to determine if elevated extracellular DA in ID was due to increased release. The DA response tol-DOPA in ID rats was 50% smaller and delayed, whereas the NE response was threefold higher. The caudate concentration of NE was also elevated in ID. Elevated dopamine-β-hydroxylase activity in ID provides a tentative explanation for the increased NE response tol-DOPA. These experiments provide new evidence that ID results in altered synthesis and functioning of DAT and perhaps suggests some compensatory changes in NE metabolism.

CATECHOLAMINES; DOPAMINE; NEUROTRANSMITTERS; PHENYLALANINE; NORADRENALINE; MESSENGER RNA

Journal of Neurochemistry, 2008, Vol 106, Issue 1, p205

0022-3042

Academic Journal

10.1111/j.1471-4159.2008.05358.x